Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study
奥希替尼及其两种活性代谢物AZ5104和AZ7550在日本晚期非小细胞肺癌患者中的群体药代动力学、药物基因组学和不良事件:一项前瞻性观察研究
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-023-01328-9
Ishikawa, Emi; Yokoyama, Yuta; Chishima, Haruna; Kasai, Hidefumi; Kuniyoshi, Ouki; Kimura, Motonori; Hakamata, Jun; Nakada, Hideo; Suehiro, Naoya; Nakaya, Naoki; Nakajima, Hideo; Ikemura, Shinnosuke; Kawada, Ichiro; Yasuda, Hiroyuki; Terai, Hideki; Jibiki, Aya; Kawazoe, Hitoshi; Soejima, Kenzo; Muramatsu, Hiroshi; Suzuki, Sayo; Nakamura, Tomonori